IceCure Medical (ICCM) Equity Ratio (2020 - 2025)
IceCure Medical (ICCM) has disclosed Equity Ratio for 5 consecutive years, with 0.55 as the latest value for Q4 2024.
- On a quarterly basis, Equity Ratio fell 25.96% to 0.55 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.55, a 25.96% decrease, with the full-year FY2024 number at 0.55, down 25.96% from a year prior.
- Equity Ratio was 0.55 for Q4 2024 at IceCure Medical, down from 0.74 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.84 in Q4 2022 to a low of 0.55 in Q4 2024.
- A 5-year average of 0.7 and a median of 0.74 in 2023 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: surged 51.39% in 2021, then dropped 25.96% in 2024.
- IceCure Medical's Equity Ratio stood at 0.55 in 2020, then surged by 51.39% to 0.84 in 2021, then increased by 0.84% to 0.84 in 2022, then decreased by 11.98% to 0.74 in 2023, then fell by 25.96% to 0.55 in 2024.
- Per Business Quant, the three most recent readings for ICCM's Equity Ratio are 0.55 (Q4 2024), 0.74 (Q4 2023), and 0.84 (Q4 2022).